nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprost Tromethamine—Polydipsia—Varenicline—nicotine dependence	0.0528	0.162	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—cardiovascular system—nicotine dependence	0.0355	0.176	CbGeAlD
Dinoprost Tromethamine—TBXA2R—G alpha (12/13) signalling events—FGD1—nicotine dependence	0.0248	0.0524	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—cardiovascular system—nicotine dependence	0.0236	0.117	CbGeAlD
Dinoprost Tromethamine—PTGIR—cardiovascular system—nicotine dependence	0.0192	0.0956	CbGeAlD
Dinoprost Tromethamine—HPGDS—midbrain—nicotine dependence	0.0184	0.0916	CbGeAlD
Dinoprost Tromethamine—TBXA2R—brain—nicotine dependence	0.0174	0.0865	CbGeAlD
Dinoprost Tromethamine—GALR3—Peptide GPCRs—OPRM1—nicotine dependence	0.0174	0.0367	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0164	0.0346	CbGpPWpGaD
Dinoprost Tromethamine—Pulmonary embolism—Varenicline—nicotine dependence	0.0164	0.0503	CcSEcCtD
Dinoprost Tromethamine—Hypertonia—Varenicline—nicotine dependence	0.0143	0.0441	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Varenicline—nicotine dependence	0.0137	0.042	CcSEcCtD
Dinoprost Tromethamine—PTGER3—brain—nicotine dependence	0.0134	0.0666	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—midbrain—nicotine dependence	0.0133	0.0659	CbGeAlD
Dinoprost Tromethamine—HPGDS—brain—nicotine dependence	0.0116	0.0575	CbGeAlD
Dinoprost Tromethamine—HPGDS—Biological oxidations—CYP2A7—nicotine dependence	0.0115	0.0243	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0114	0.0242	CbGpPWpGaD
Dinoprost Tromethamine—Hypokalaemia—Varenicline—nicotine dependence	0.0108	0.0332	CcSEcCtD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—TAS2R16—nicotine dependence	0.00991	0.0209	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—brain—nicotine dependence	0.00944	0.0469	CbGeAlD
Dinoprost Tromethamine—SLC22A7—brain—nicotine dependence	0.00897	0.0446	CbGeAlD
Dinoprost Tromethamine—SLC22A6—brain—nicotine dependence	0.00866	0.0431	CbGeAlD
Dinoprost Tromethamine—Epistaxis—Varenicline—nicotine dependence	0.00863	0.0265	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Varenicline—nicotine dependence	0.00837	0.0257	CcSEcCtD
Dinoprost Tromethamine—SLCO3A1—brain—nicotine dependence	0.00833	0.0414	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—brain—nicotine dependence	0.00825	0.041	CbGeAlD
Dinoprost Tromethamine—GALR3—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.00818	0.0173	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—TAS2R16—nicotine dependence	0.00768	0.0162	CbGpPWpGaD
Dinoprost Tromethamine—Angiopathy—Varenicline—nicotine dependence	0.00746	0.0229	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Varenicline—nicotine dependence	0.00742	0.0228	CcSEcCtD
Dinoprost Tromethamine—Chills—Varenicline—nicotine dependence	0.00737	0.0227	CcSEcCtD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—TAS2R16—nicotine dependence	0.00693	0.0146	CbGpPWpGaD
Dinoprost Tromethamine—Back pain—Varenicline—nicotine dependence	0.00692	0.0213	CcSEcCtD
Dinoprost Tromethamine—GALR3—G alpha (i) signalling events—OPRM1—nicotine dependence	0.0069	0.0146	CbGpPWpGaD
Dinoprost Tromethamine—Muscle spasms—Varenicline—nicotine dependence	0.00688	0.0211	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Varenicline—nicotine dependence	0.00664	0.0204	CcSEcCtD
Dinoprost Tromethamine—Agitation—Varenicline—nicotine dependence	0.00657	0.0202	CcSEcCtD
Dinoprost Tromethamine—Malaise—Varenicline—nicotine dependence	0.00645	0.0198	CcSEcCtD
Dinoprost Tromethamine—Syncope—Varenicline—nicotine dependence	0.00641	0.0197	CcSEcCtD
Dinoprost Tromethamine—GALR3—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.0064	0.0135	CbGpPWpGaD
Dinoprost Tromethamine—Loss of consciousness—Varenicline—nicotine dependence	0.00629	0.0193	CcSEcCtD
Dinoprost Tromethamine—Cough—Varenicline—nicotine dependence	0.00624	0.0192	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Varenicline—nicotine dependence	0.0062	0.0191	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Varenicline—nicotine dependence	0.00618	0.019	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Varenicline—nicotine dependence	0.00609	0.0187	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Varenicline—nicotine dependence	0.00602	0.0185	CcSEcCtD
Dinoprost Tromethamine—Infection—Varenicline—nicotine dependence	0.0058	0.0178	CcSEcCtD
Dinoprost Tromethamine—Shock—Varenicline—nicotine dependence	0.00574	0.0177	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Varenicline—nicotine dependence	0.0057	0.0175	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Varenicline—nicotine dependence	0.00564	0.0173	CcSEcCtD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0056	0.0118	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00549	0.0116	CbGpPWpGaD
Dinoprost Tromethamine—Hypotension—Varenicline—nicotine dependence	0.00546	0.0168	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Varenicline—nicotine dependence	0.0052	0.016	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Varenicline—nicotine dependence	0.00519	0.016	CcSEcCtD
Dinoprost Tromethamine—SLC22A8—brain—nicotine dependence	0.00519	0.0258	CbGeAlD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—TAS2R16—nicotine dependence	0.00518	0.0109	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—TAS2R16—nicotine dependence	0.00509	0.0107	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—TAS2R16—nicotine dependence	0.00507	0.0107	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00507	0.0107	CbGpPWpGaD
Dinoprost Tromethamine—Pain—Varenicline—nicotine dependence	0.00499	0.0153	CcSEcCtD
Dinoprost Tromethamine—GALR3—G alpha (i) signalling events—DRD2—nicotine dependence	0.00499	0.0105	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00496	0.0105	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00483	0.0102	CbGpPWpGaD
Dinoprost Tromethamine—Feeling abnormal—Varenicline—nicotine dependence	0.00481	0.0148	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Varenicline—nicotine dependence	0.00477	0.0147	CcSEcCtD
Dinoprost Tromethamine—GALR3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00463	0.00977	CbGpPWpGaD
Dinoprost Tromethamine—Abdominal pain—Varenicline—nicotine dependence	0.00461	0.0142	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Varenicline—nicotine dependence	0.00461	0.0142	CcSEcCtD
Dinoprost Tromethamine—PTGER3—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00448	0.00946	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—FGD1—nicotine dependence	0.00439	0.00928	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00434	0.00917	CbGpPWpGaD
Dinoprost Tromethamine—Hypersensitivity—Varenicline—nicotine dependence	0.0043	0.0132	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00425	0.00898	CbGpPWpGaD
Dinoprost Tromethamine—Asthenia—Varenicline—nicotine dependence	0.00419	0.0129	CcSEcCtD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—OPRM1—nicotine dependence	0.00418	0.00882	CbGpPWpGaD
Dinoprost Tromethamine—SLCO2A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00414	0.00875	CbGpPWpGaD
Dinoprost Tromethamine—Pruritus—Varenicline—nicotine dependence	0.00413	0.0127	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Varenicline—nicotine dependence	0.00399	0.0123	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—FGD1—nicotine dependence	0.00399	0.00843	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00397	0.00837	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—TAS2R16—nicotine dependence	0.00394	0.00833	CbGpPWpGaD
Dinoprost Tromethamine—SLCO3A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00393	0.00829	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00392	0.00827	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00388	0.00819	CbGpPWpGaD
Dinoprost Tromethamine—Dizziness—Varenicline—nicotine dependence	0.00386	0.0119	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00384	0.0081	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Varenicline—nicotine dependence	0.00371	0.0114	CcSEcCtD
Dinoprost Tromethamine—Rash—Varenicline—nicotine dependence	0.00368	0.0113	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Varenicline—nicotine dependence	0.00368	0.0113	CcSEcCtD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00367	0.00776	CbGpPWpGaD
Dinoprost Tromethamine—Headache—Varenicline—nicotine dependence	0.00366	0.0112	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00359	0.00758	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—TAS2R16—nicotine dependence	0.00356	0.00751	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—G alpha (i) signalling events—DRD2—nicotine dependence	0.00349	0.00737	CbGpPWpGaD
Dinoprost Tromethamine—Nausea—Varenicline—nicotine dependence	0.00347	0.0107	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—FGD1—nicotine dependence	0.00341	0.00719	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00335	0.00707	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00328	0.00692	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00328	0.00692	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—OPRM1—nicotine dependence	0.00324	0.00684	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00324	0.00684	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—FGD1—nicotine dependence	0.00309	0.00653	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00308	0.00649	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—FGD1—nicotine dependence	0.00307	0.00649	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—DRD2—nicotine dependence	0.00302	0.00638	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TAS2R16—nicotine dependence	0.003	0.00634	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—CHRNB3—nicotine dependence	0.00297	0.00627	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00293	0.00618	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—OPRM1—nicotine dependence	0.00292	0.00617	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00287	0.00606	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00287	0.00605	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00287	0.00605	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—CHRNA6—nicotine dependence	0.00282	0.00595	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00281	0.00593	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00281	0.00593	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—FGD1—nicotine dependence	0.00279	0.00589	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00277	0.00586	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—TAS2R16—nicotine dependence	0.00266	0.00562	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00266	0.00561	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—TAS2R16—nicotine dependence	0.0026	0.0055	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—TAS2R16—nicotine dependence	0.0026	0.0055	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00255	0.00538	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00242	0.00511	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00237	0.005	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00237	0.005	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00237	0.005	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—OPRM1—nicotine dependence	0.00236	0.00498	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—FGD1—nicotine dependence	0.00236	0.00498	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—DRD2—nicotine dependence	0.00234	0.00495	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TAS2R16—nicotine dependence	0.00233	0.00492	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—FGD1—nicotine dependence	0.0023	0.00485	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—FGD1—nicotine dependence	0.00225	0.00475	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—FGD1—nicotine dependence	0.00225	0.00475	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—OPRM1—nicotine dependence	0.00218	0.00461	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—OPRM1—nicotine dependence	0.00214	0.00453	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—OPRM1—nicotine dependence	0.00214	0.00452	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—OPRM1—nicotine dependence	0.00214	0.00452	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—DRD2—nicotine dependence	0.00211	0.00446	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TAS2R16—nicotine dependence	0.0021	0.00444	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—FGD1—nicotine dependence	0.00209	0.00441	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—AKR1B10—nicotine dependence	0.00208	0.0044	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00207	0.00438	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00206	0.00436	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—FGD1—nicotine dependence	0.00204	0.00431	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—FGD1—nicotine dependence	0.00204	0.00431	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—GABRA4—nicotine dependence	0.00204	0.0043	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00203	0.00429	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00203	0.00429	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—CYP2A7—nicotine dependence	0.00197	0.00416	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—CHRNB4—nicotine dependence	0.00195	0.00412	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00193	0.00408	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00187	0.00395	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—OPRM1—nicotine dependence	0.00183	0.00387	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—FGD1—nicotine dependence	0.00183	0.00386	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—CHRNA5—nicotine dependence	0.00181	0.00383	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—DRD2—nicotine dependence	0.00171	0.0036	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.0017	0.00359	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—OPRM1—nicotine dependence	0.00166	0.00351	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—OPRM1—nicotine dependence	0.00165	0.00349	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—FGD1—nicotine dependence	0.00165	0.00348	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—AKR1B10—nicotine dependence	0.00161	0.00341	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—DRD2—nicotine dependence	0.00158	0.00334	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00157	0.00332	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TAS2R16—nicotine dependence	0.00157	0.00332	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—DRD2—nicotine dependence	0.00155	0.00327	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—DRD2—nicotine dependence	0.00155	0.00326	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—DRD2—nicotine dependence	0.00155	0.00326	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00154	0.00326	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TAS2R16—nicotine dependence	0.00154	0.00325	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TAS2R16—nicotine dependence	0.00154	0.00325	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—OPRM1—nicotine dependence	0.0015	0.00317	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—CHRNA3—nicotine dependence	0.00148	0.00312	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—WASF2—nicotine dependence	0.00147	0.0031	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—AKR1B10—nicotine dependence	0.00146	0.00308	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—WASF1—nicotine dependence	0.00141	0.00297	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—DRD2—nicotine dependence	0.00132	0.00279	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00131	0.00277	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—CHRNB2—nicotine dependence	0.0013	0.00275	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—OPRM1—nicotine dependence	0.00127	0.00267	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—OPRM1—nicotine dependence	0.00123	0.00261	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—FGD1—nicotine dependence	0.00123	0.0026	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—OPRM1—nicotine dependence	0.00121	0.00255	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—OPRM1—nicotine dependence	0.00121	0.00255	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—FGD1—nicotine dependence	0.00121	0.00255	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—FGD1—nicotine dependence	0.00121	0.00255	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—DRD2—nicotine dependence	0.0012	0.00254	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—DRD2—nicotine dependence	0.00119	0.00252	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—CHRNA4—nicotine dependence	0.00118	0.0025	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—WASF2—nicotine dependence	0.00114	0.0024	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—OPRM1—nicotine dependence	0.00112	0.00237	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—OPRM1—nicotine dependence	0.0011	0.00232	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—OPRM1—nicotine dependence	0.0011	0.00232	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00109	0.00231	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—WASF1—nicotine dependence	0.00109	0.0023	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—AKR1B10—nicotine dependence	0.00109	0.0023	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—DRD2—nicotine dependence	0.00108	0.00229	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—AKR1B10—nicotine dependence	0.00107	0.00225	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—AKR1B10—nicotine dependence	0.00107	0.00225	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—WASF2—nicotine dependence	0.00103	0.00217	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—WASF1—nicotine dependence	0.000984	0.00208	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—OPRM1—nicotine dependence	0.000982	0.00207	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—DRD2—nicotine dependence	0.000916	0.00193	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—DRD2—nicotine dependence	0.000893	0.00188	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—OPRM1—nicotine dependence	0.000886	0.00187	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—DRD2—nicotine dependence	0.000874	0.00184	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—DRD2—nicotine dependence	0.000874	0.00184	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—DRD2—nicotine dependence	0.000811	0.00171	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—DRD2—nicotine dependence	0.000793	0.00168	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—DRD2—nicotine dependence	0.000793	0.00168	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—WASF2—nicotine dependence	0.000767	0.00162	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—WASF2—nicotine dependence	0.000751	0.00159	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—WASF2—nicotine dependence	0.000751	0.00159	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—WASF1—nicotine dependence	0.000736	0.00155	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—WASF1—nicotine dependence	0.00072	0.00152	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—WASF1—nicotine dependence	0.00072	0.00152	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—DRD2—nicotine dependence	0.00071	0.0015	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—OPRM1—nicotine dependence	0.000662	0.0014	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—OPRM1—nicotine dependence	0.000648	0.00137	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—OPRM1—nicotine dependence	0.000648	0.00137	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—DRD2—nicotine dependence	0.00064	0.00135	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CYP2A7—nicotine dependence	0.000513	0.00108	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—DRD2—nicotine dependence	0.000479	0.00101	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—DRD2—nicotine dependence	0.000469	0.00099	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—DRD2—nicotine dependence	0.000469	0.00099	CbGpPWpGaD
